Agent for curing peripheral circulation insufficiency
AssigneeYamanouchi Pharmaceutical Co., Ltd.
InventorsHiroshi Maeda, Katsuhide Nishi
Life of this patent
Estimating the term…
Loading patent…
AssigneeYamanouchi Pharmaceutical Co., Ltd.
InventorsHiroshi Maeda, Katsuhide Nishi
Estimating the term…
An agent for curing peripheral circulation insufficiency comprising .alpha..sub.1 -acid glycoprotein. A blood flow in peripheral blood vessels cause a trouble by hardening of the blood vessels, lowering of blood pressure or acceleration of a fibrinolysinemia function to bring about peripheral circulation insufficiency. But .alpha..sub.1 -acid glycoprotein has a function that it prevents coagulation and agglutination of the solid component in the blood and, particularly, it accelerates passability of the red blood corpuscles in the vital peripheral circulation system to alleviate or remove the peripheral circulation insufficiency. .alpha..sub.1 -acid glycoprotein has very low toxicity and is preferred to be administered into an artery or a vein in a form of preparation for injection, etc.
A method of curing peripheral circulation insufficiency comprising administering a therapeutically effective amount of .alpha..sub.1 -acid glycoprotein to a patient suffering from the same.
Dependencies are inferred from the claim text.